# OnCo record sorrento-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/sorrento-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "sorrento-therapeutics" ;
  schema:name "Sorrento Therapeutics"@en ;
  schema:alternateName "Sorrento Therapeutics, Inc."@en, "Sorrento"@en ;
  schema:description "Sorrento was a San Diego biotech with a sprawling pipeline of antibodies, cell therapies and a resiniferatoxin pain programme for cancer pain; it filed for bankruptcy in 2023."@en ;
  schema:url <https://onco.cc/companies/sorrento-therapeutics/>, <http://sorrentotherapeutics.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <http://sorrentotherapeutics.com>, <https://clinicaltrials.gov/search?lead=Sorrento%20Therapeutics%2C%20Inc.>, <https://www.wikidata.org/wiki/Q30288730> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/pain-management/> ;
  onco:drugs <https://onco.cc/drugs/sti-6129/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .